CompuMed, Inc.
CMPD · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $5 | $5 | $7 | $14 |
| - Cash | $2 | $1 | $2 | $2 |
| + Debt | $1 | $0 | $1 | $1 |
| Enterprise Value | $4 | $4 | $5 | $12 |
| Revenue | $6 | $6 | $6 | $6 |
| % Growth | 6.6% | -8.3% | 0.8% | – |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 48.6% | 49.4% | 51.9% | 53% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 15.3% | 11.8% | 17.6% | 23.4% |
| Net Income | $0 | -$0 | $1 | $1 |
| % Margin | 3.1% | -0.6% | 7.9% | 16.9% |
| EPS Diluted | 0.15 | -0.021 | 0.3 | 0.69 |
| % Growth | 817.7% | -107% | -56.5% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$1 | -$0 | -$1 | -$1 |
| Free Cash Flow | $0 | $0 | -$0 | $1 |